This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Michal Harel: Innovator in Enzymatic Activity Correction
Introduction
Michal Harel is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biochemistry, particularly in the area of enzymatic activity correction. His innovative work has led to the development of a unique patent that addresses critical issues related to glucocerebrosidase molecules.
Latest Patents
Harel holds a patent for a "Partially deglycosylated glucocerebrosidase polypeptide and crystals thereof." This patent outlines a method for identifying compounds capable of correcting impaired enzymatic activity in mutant glucocerebrosidase molecules. The method involves obtaining a first set of structure coordinates that define a 3D structure of a normal glucocerebrosidase molecule. It also includes computationally generating a second set of structure coordinates for the mutant molecule and identifying compounds that can interact with it to restore its enzymatic function. Harel's work is crucial for advancing therapeutic approaches for conditions related to glucocerebrosidase deficiencies. He has 1 patent to his name.
Career Highlights
Michal Harel is associated with Yeda Research and Development Co. Ltd., where he has been instrumental in driving research initiatives. His expertise in enzymatic processes has positioned him as a key figure in the development of innovative solutions in biochemistry.
Collaborations
Harel has collaborated with notable scientists in his field, including Anthony Futerman and Joel L. Sussman. These collaborations have further enriched his research and contributed to the advancement of knowledge in enzymatic activity correction.
Conclusion
Michal Harel's contributions to the field of biochemistry through his innovative patent and collaborative efforts highlight his role as a leading inventor. His work continues to pave the way for advancements in therapeutic solutions for enzymatic deficiencies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile